Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon crossover trial for pancreatic exocrine insufficiency after major upper gastrointestinal surgery
ACTRN12613000269730Phase 4Recruiting
- Sponsor
- Box Hill Hospital
- Start
- Jun 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of pancreatin in exocrine pancreatic insufficiency (EPI) (2 arms), sponsored by Box Hill Hospital. Primary endpoints: Weight, Bowel function and 1 more. Started Jun 2013; status: recruiting.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on ACTRN12613000269730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000269730.